These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4210027)

  • 21. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
    Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Single intravenous glibenclamide-glucose loading as a prediction test (author's transl)].
    Pfeiffer EF; Raptis S; Schröder KE
    Dtsch Med Wochenschr; 1974 Jun; 99(24):1281-94. PubMed ID: 4210532
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral glucose-stimulated insulin release in nondiabetic twin siblings of diabetic twins.
    Gottlieb MS; Soeldner JS; Kyner JL; Gleason RE
    Diabetes; 1974 Aug; 23(8):684-92. PubMed ID: 4853483
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.
    Haupt E; Köberich W; Beyer J; Schöffling K
    Diabetologia; 1971 Dec; 7(6):455-60. PubMed ID: 5004179
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of glibenclamide in the therapy of diabetes].
    Parodi FA
    Minerva Med; 1972 Apr; 63(28):1629-32. PubMed ID: 4623326
    [No Abstract]   [Full Text] [Related]  

  • 26. Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease.
    Hernandez A; Zorrilla E; Gershberg H
    J Lab Clin Med; 1969 Jan; 73(1):25-33. PubMed ID: 5762161
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum insulin and growth hormone in lipoatrophic diabetes.
    Samaan NA; Craig JW
    Metabolism; 1969 Jun; 18(6):460-8. PubMed ID: 4891081
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies in prediabetes. Insulin response to oral glucose, intravenous tolbutamide and rapid intravenous glucose infusion in genetic prediabetics.
    Serrano-Rios M; Ramos F; Rodriguez-Miñon JL; Vivanco F
    Diabetologia; 1970 Aug; 6(4):392-8. PubMed ID: 5456764
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of medroxyprogesterone acetate on serum insulin and growth hormone levels in diabetics and potential diabetics.
    Gershberg H; Zorrilla E; Hernandez A; Hulse M
    Obstet Gynecol; 1969 Mar; 33(3):383-9. PubMed ID: 5776088
    [No Abstract]   [Full Text] [Related]  

  • 30. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
    [No Abstract]   [Full Text] [Related]  

  • 31. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 32. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 33. Diurnal variation in glucose tolerance and in insulin secretion in man.
    Carroll KF; Nestel PJ
    Diabetes; 1973 May; 22(5):333-48. PubMed ID: 4700047
    [No Abstract]   [Full Text] [Related]  

  • 34. The early partial remission of juvenile diabetes mellitus. The roles of insulin and growth hormone.
    Baker L; Kaye R; Root AW
    J Pediatr; 1967 Dec; 71(6):825-31. PubMed ID: 6075208
    [No Abstract]   [Full Text] [Related]  

  • 35. [Extrapancreatic effects of oral sulfonylureas].
    Beyer J; Cordes U; Krall H; Rosak C; Schöffling K
    Verh Dtsch Ges Inn Med; 1971; 77():539-43. PubMed ID: 5155894
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral substitutes for insulin: modern appraisal of their action and indications.
    Isr J Med Sci; 1972 Jun; 8(6):677-710. PubMed ID: 4626310
    [No Abstract]   [Full Text] [Related]  

  • 37. Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone.
    Sönksen PH; Lowy C; Perkins JR; West TE
    Diabetologia; 1981; 20(1):22-30. PubMed ID: 6781962
    [No Abstract]   [Full Text] [Related]  

  • 38. Glucose, FFA, IRI and GH response to I.V. glibenclamide.
    Rastogi GK; Dash RJ; Sinha MK
    Horm Metab Res; 1973 Jul; 5(4):303. PubMed ID: 4199903
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mechanism of action of gliquidone (author's transl)].
    Zilker T; Ermler R; Henderkott U; Bottermann P
    Dtsch Med Wochenschr; 1975 Aug; 100(35):1733-4, 1739-41. PubMed ID: 808405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of dimethylbiguanide on glucose tolerance, serum insulin and growth hormone in obese patients.
    Schatz H; Doci S; Höfer R
    Diabetologia; 1972 Feb; 8(1):1-7. PubMed ID: 5027232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.